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ABSTRACT Human cytomegalovirus (HCMV) latency is an active process which re-
models the latently infected cell to optimize latent carriage and reactivation. This is
achieved, in part, through the expression of viral genes, including the G-protein-
coupled receptor US28. Here, we use an unbiased proteomic screen to assess
changes in host proteins induced by US28, revealing that interferon-inducible genes
are downregulated by US28. We validate that major histocompatibility complex
(MHC) class II and two pyrin and HIN domain (PYHIN) proteins, myeloid cell nuclear
differentiation antigen (MNDA) and IFI16, are downregulated during experimental la-
tency in primary human CD14 monocytes. We ﬁnd that IFI16 is targeted rapidly
during the establishment of latency in a US28-dependent manner but only in undif-
ferentiated myeloid cells, a natural site of latent carriage. Finally, by overexpressing
IFI16, we show that IFI16 can activate the viral major immediate early promoter and
immediate early gene expression during latency via NF-B, a function which explains
why downregulation of IFI16 during latency is advantageous for the virus.
IMPORTANCE Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus which in-
fects 50 to 100% of humans worldwide. HCMV causes a lifelong subclinical infection
in immunocompetent individuals but is a serious cause of mortality and morbidity in
the immunocompromised and neonates. In particular, reactivation of HCMV in the
transplant setting is a major cause of transplant failure and related disease. There-
fore, a molecular understanding of HCMV latency and reactivation could provide in-
sights into potential ways to target the latent viral reservoir in at-risk patient popu-
lations.
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Lifelong persistence of human cytomegalovirus (HCMV) is underpinned by virallatency and reactivation. Following primary infection, the ubiquitous betaherpesvi-
rus HCMV establishes latency in cell types, including early myeloid lineage cells (1–4).
The viral genome is maintained in these cells in the relative absence of immediate early
(IE) gene expression or production of infectious virions. Reactivation of HCMV is
associated with differentiation of myeloid lineage cells to mature dendritic cells and
macrophages; as such, reactivation events are thought to occur sporadically through-
out the lifetime of the host (5–8). In immunocompetent individuals, both primary
infection and reactivation events are well controlled by a broad and robust immune
response (9). However, HCMV reactivation is a major cause of morbidity and mortality
in immunocompromised patients, including stem cell and organ transplant recipients
(10, 11).
A key hallmark of latency is the relative suppression of IE gene expression (1, 2,
12–14), which is controlled by the major immediate early promoter (MIEP) (15–17), and
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the subsequent lack of infectious virion production. The establishment of latency via
MIEP repression in early myeloid lineage cells requires both host and viral factors (18).
One viral factor that suppresses MIEP activity is the G-protein-coupled receptor (GPCR)
US28, a virally encoded chemokine receptor homologue, which is expressed de novo
during latency as well as being delivered to cells with the incoming virion (19–24), and
this incoming viral US28 is functional (25). US28 modulates the signaling pathways of
early myeloid cells; it attenuates mitogen-activated protein (MAP) kinases, NF-B, and
c-fos, while activating STAT3 and inducible nitric oxide synthase (iNOS) (21, 23, 25). All
of these contribute to the repression of MIEP activity. This US28-mediated signaling is
so critical to latency that US28-deleted viruses, or the loss of G-protein coupling by the
US28 mutant R129A, results in lytic infection of undifferentiated myeloid cells (19, 21,
23, 25). Furthermore, when examined, these US28-mediated effects on cell signaling
did not occur during lytic infection or in permissive cells (21), implying that US28
represses the MIEP during latency but does not impair reactivation following cellular
differentiation. This is reﬂective of the cell type-speciﬁc nature of US28-mediated
signaling (21, 26).
Since US28 can modulate all these pathways and control the MIEP, we hypothesized
that US28 would also cause changes in host protein expression. Here, we perform a
proteomic screen comparing host cell protein abundance in myelomonocytic THP-1
cells expressing wild-type US28 (US28-WT) or the US28-R129A signaling mutant. We
ﬁnd that the expression of many host proteins are decreased in the presence of
US28-WT compared with the US28-R129A mutant and that a large proportion of these
proteins are interferon inducible. In particular, the two pyrin and HIN domain (PYHIN)
family proteins, myeloid cell nuclear differentiation antigen (MNDA) and gamma inter-
feron (IFN-)-inducible protein 16 (IFI16), are downregulated by US28, as well as major
histocompatibility complex (MHC) class II proteins. IFI16 is associated with the nuclear
sensing of herpesvirus DNA (27–31) and control of herpesvirus gene expression (32–39)
and also represses viral transcription during HIV latency (40), but the effects of IFI16 on
HCMV latent infection are unknown. Downregulation of HLA-DR/MHC class II is impor-
tant for the evasion of CD4 T cell responses to latently infected myeloid cells (41),
while antiviral effects of MNDA have yet to be reported.
We have validated the downregulation of IFI16, MNDA, and HLA-DR in US28-
expressing THP-1 cells and during experimental latency in primary CD14 monocytes.
We ﬁnd that HCMV downregulates IFI16 within the ﬁrst 24 h of infection of myeloid
cells in a US28-dependent manner, but this effect is lost in differentiated dendritic cells.
We propose that downregulation of IFI16 is beneﬁcial to the establishment of latency
because overexpression of IFI16 drives MIEP activity and IE gene expression via NF-B.
By targeting the downregulation of IFI16, US28 actively promotes the establishment of
latency in early myeloid lineage cells.
RESULTS
Proteomic analysis reveals US28-induced changes in host proteins in myeloid
cells. US28-mediated signaling is critical to latency: US28-deleted viruses, or the loss of
G-protein coupling by the US28 mutant R129A, results in lytic infection of undifferen-
tiated myeloid cells (19, 21, 23, 25). Similarly, infection of US28-WT-expressing THP-1
cells with US28 deletion viruses leads to complementation and the establishment of
latency; both the US28-R129A- and empty-vector-expressing cell lines fail to establish
latent infection under these conditions (21). Therefore, to understand how US28-WT
alters the host cell environment to support latency, we analyzed the total proteomes of
myelomonocytic THP-1 cell lines which express either US28-WT (sequence derived from
the VHL/E strain of HCMV), signaling mutant US28-R129A, or the empty vector (EV)
control (Fig. 1A to C; see also Data Set S1 in the supplemental material).
By using these three cell lines, we were able to identify host cell proteins modulated
by US28 expression in a G-protein signaling-dependent and -independent manner.
Changes in host protein abundance common between cells expressing US28-WT and
US28-R129A compared to cells expressing empty vector (Fig. 1B and C) represent
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FIG 1 US28 induces changes in the host proteome of THP-1 cells. (A to C) THP-1 cells expressing empty vector, US28-WT, and US28-R129A were subjected
to total cell proteomic analysis using a TMT labeling approach as described in Materials and Methods. Each circle represents one human protein and is shown
in gray if its abundance changes by a factor of less than 2, in red if between 2- and 4-fold, and in purple if greater than 4-fold. The exception is components
of the HLA-DR complex, which are represented by pink triangles. The dotted line represents a signiﬁcance threshold of a q value of 0.001; a q value of  0.001
is considered signiﬁcant. q values of signiﬁcance between groups were calculated by Benjamini-Hochberg correction of P values generated using the moderated
T-test LIMMA within the R environment. Comparison of US28-WT and US28-R129A (A), US28-WT and empty vector (B), and US28-R129A and empty vector (C).
In each case, the relative abundance of human proteins MNDA and IFI16 is marked with a black arrowhead or arrow. (D) Analysis of the top 40 downregulated
(Continued on next page)
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signaling-independent changes, and these include CD44 and CD82 proteins, which are
each downregulated by both sets of US28-expressing cells.
While we do not rule out the possibility that signaling independent changes in
myeloid cells driven by US28 may be important for HCMV latency, G-protein-dependent
signaling is absolutely required for latency, and therefore, we were particularly inter-
ested in the direct comparison of host protein abundances in THP-1 cells expressing
US28-WT and US28-R129A (Fig. 1A). This comparison reveals 42 host proteins whose
expression is twofold or more increased or decreased by US28-WT, and our analyses
focused on these signaling-dependent changes.
One remarkable feature of many of the most downregulated proteins in Fig. 1A is
that they are interferon inducible (Fig. 1D; see also Fig. S1A in the supplemental
material). According to the Interferome database (v2.01) (www.interferome.org) (42),
two-thirds (27/40) of the most downregulated proteins (fold change 1.86-fold or
higher) we identiﬁed are type I or type II interferon inducible (Fig. 1D). In contrast, of
the 40 proteins which showed no changes (fold change  0) in abundance between
US28-WT and US28-R129A, 12/40 (30%) were included in the Interferome database
(Data Set S1). Importantly, overexpression of the multipass membrane US28 proteins
did not lead to induction of the unfolded protein response or other endoplasmic-stress-
related genes (Fig. S1B), suggesting that the changes identiﬁed in the screen are not
general effects of protein overexpression.
Since STAT1 phosphorylation is common to both the type I and type II interferon
signaling pathways (43), we examined total STAT1 and phosphorylated STAT1 in
US28-WT cells. We found that US28-WT cells had lower overall levels of STAT1 and
phosphorylated STAT1 compared to cells transduced with US28-R129A or empty vector
control (Fig. 1E and F). Furthermore, when correcting for total levels of STAT1, we found
that US28-WT cells had lower relative levels of phosphorylated STAT1 compared with
US28-R129A (Fig. 1E and G). This could help explain why US28-WT downregulated
many interferon-inducible genes in our proteomic screen.
IFI16, MNDA, and HLA-DR are all downregulated by US28. Several interferon-
inducible proteins showing decreased expression were of interest as potentially im-
portant targets for US28 during HCMV latency. These proteins included MNDA (nine
unique peptides; 5.0-fold downregulated compared to US28-R129A), IFI16 (four unique
peptides; 2.4-fold downregulated compared to US28-R129A), and components of the
MHC class II HLA-DR complex (three to six unique peptides; between 1.9- and 2.2-fold
downregulated compared to US28-R129A). We began by conﬁrming US28-WT-
mediated downregulation of these proteins in independently transduced US28-
expressing THP-1 cells. After generating these fresh US28-expressing cell lines, we
checked expression levels of US28-WT or US28-R129A by reverse transcription-
quantitative PCR (RT-qPCR) (Fig. S2A) and Western blotting (Fig. S2B and S2C). RT-qPCR
conﬁrmed that IFI16, MNDA, and HLA-DRA transcripts are all downregulated in US28-
WT-expressing cells compared to those expressing the signaling mutant R129A
(Fig. 2A). Subsequently, we conﬁrmed this US28-WT-mediated downregulation of IFI16
and MNDA at the protein level by Western blotting (Fig. 2B and C and Fig. S2D, S2E, and
S2F) or by ﬂow cytometry for cell surface HLA-DR (Fig. 2F and G), although both
US28-WT and US28-R129A cells responded similarly to gamma interferon (IFN-) stim-
ulation, by upregulating HLA-DR to similar levels (Fig. 2F). This suggests that, while
US28 is able to downregulate constitutive HLA-DR expression, it is unable to prevent its
induction by IFN-. Furthermore, this downregulation was not due to strain-speciﬁc
FIG 1 Legend (Continued)
proteins identiﬁed in panel A. After ﬁltering for changes with a q value of 0.001, the gene names were entered in the Interferome database. Proteins that
are induced by type I and/or type II interferon are depicted in the Venn diagram. Proteins that we identiﬁed that are not interferon inducible are listed below
(under “Neither”). (E) Lysates from THP-1 cells expressing empty vector (EV), US28-WT, and US28-R129A were assessed by Western blotting for phospho-STAT1
(Tyr701), total STAT1, and beta-actin (loading control). (F and G) Quantiﬁcation of STAT1 and phospho-STAT1 band intensity from two Western blots from two
independent samples of transduced THP-1 cells. (F) Quantiﬁcation of the indicated protein levels normalized to actin. (G) Quantiﬁcation of phospho-STAT1 levels
relative to total STAT1.
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effects of US28, as US28-WT also downregulated HLA-DR when the US28 sequence
from the TB40/E strain of HCMV was used to transduce THP-1 cells (Fig. S3A to D).
Since US28 attenuates c-fos signaling (25) and STAT1 phosphorylation (Fig. 1E to G),
and both HLA-DR and IFI16 are fos and STAT1-responsive genes (44–48), we hypoth-
esized that one or both of these mechanisms is responsible for US28-mediated down-
regulation of IFI16 and HLA-DR. To test this, we treated THP-1 cells expressing empty
vector, US28-WT, and US28-R129A with the Janus kinase inhibitor Ruxolitinib or the
c-fos inhibitor T-5224. Ruxolitinib partially downregulated IFI16 expression in all three
cell types (Fig. 2D) but downregulated HLA-DR only in the US28-R129A-expressing cell
line (Fig. 2H), despite a complete block in STAT1 phosphorylation (Fig. S2G). The c-fos
inhibitor reduced IFI16 and HLA-DR expression in comparison with dimethyl sulfoxide
(DMSO) controls in empty-vector -and R129A cell lines, and in the case of empty vector,
this drop in expression was almost down to the level in untreated US28-WT cells (Fig. 2E
and H). Taken together, we think it likely that both c-fos and STAT1 attenuation are
important for US28-mediated downregulation of IFI16 and HLA-DR. Interestingly, the
c-fos inhibitor actually increased IFI16 expression in US28-WT-expressing cells. We think
that this could be due to a basal level of c-fos being required for the expression of a
host gene, as yet unidentiﬁed, that is needed by US28-WT to attenuate multiple
FIG 2 US28-expressing cell lines downregulate IFI16, MNDA, and HLA-DR. (A) Relative RNA expression of IFI16, MNDA, and HLA-DR in US28-expressing THP-1
cells. The levels of IFI16, MNDA, and HLA-DRA were normalized to the levels of TBP and then to US28-R129A using the ΔΔCt method. (B and C) Lysates from
cells expressing US28-WT and US28-R129A were analyzed by Western blotting for IFI16 (B) and MNDA (C) expression; actin is shown as a loading control.
(D) Cells expressing empty vector (EV), US28-WT, and US28-R129A were treated with 5 M ruxolitinib () or with an equivalent concentration of DMSO (),
for 48 h, before analysis for IFI16 expression by Western blotting, using actin as a loading control. (E) As in panel D, except that cells were treated with T-5224
at 10 M, DMSO, or left untreated (UT). (F) US28-expressing cells were maintained in culture media only (left panel) or treated with 1 ng/ml of IFN- (right panel)
for 24 h before staining for cell surface HLA-DR by ﬂow cytometry. Staining was performed in triplicate for untreated cells, and the mean of these is experiments
is presented in panel G as mean ﬂuorescence intensity with standard deviation. Statistical analysis was performed by one-way analysis of variance (ANOVA),
and statistical signiﬁcance is indicated by a bar and asterisks as follows: ***, P  0.001. (H) As in panels D and E, except cells were analyzed for cell surface
HLA-DR by ﬂow cytometry, and results are presented as mean ﬂuorescence intensity with 95% conﬁdence intervals. Statistical analysis was performed by
two-way ANOVA using Bonferroni’s multiple-comparison test, and statistical signiﬁcance is indicated as follows: ns, not signiﬁcant (P  0.01); ****, P  0.0001.
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signaling pathways; one candidate gene for this is the AP-1-inducible phosphatase
DUSP1 (49) which will require further investigation.
Latent infection of monocytes is associated with the downregulation of IFI16,
MNDA, and HLA-DR. Having conﬁrmed key observations from our proteomic data in
transduced THP-1 cells overexpressing US28 in isolation, we then sought to determine
whether IFI16, MNDA, and HLA-DR are also downregulated in an experimental model
of latency in ex vivo primary CD14 monocytes where latency-associated expression of
US28 is well established. To do this, we infected CD14 monocytes with TB40/E-BAC4
strains of HCMV engineered to express either green ﬂuorescent protein (GFP) or
mCherry as markers for latent or lytic infection. First, we analyzed CD14 monocytes
infected with TB40/E SV40 mCherry/IE2-2A-GFP. This virus drives constitutive mCherry
expression in all infected cells via the simian virus 40 (SV40) promoter, but GFP
expression is restricted to lytically infected cells as a result of IE2 expression, which is
linked to GFP by the self-cleaving peptide 2A. Therefore, we were able to distinguish
IE2-positive (lytic) cells from IE2-negative cells (one hallmark of latency) among in-
fected, mCherry-positive cells. At 4 days postinfection (d.p.i.), we ﬁxed and immuno-
stained the monocytes for our cellular proteins of interest in mCherry-positive, IE2-2A-
GFP-negative cells (Fig. 3A). For a control, we also differentiated monocytes with
phorbol 12-myristate 12-acetate (PMA), which drives IE2-2A-GFP expression through
differentiation-dependent reactivation. We found that IFI16, MNDA, and HLA-DR were
all downregulated in latently infected, mCherry-positive but IE2-negative, CD14
monocytes. Importantly, this comparison held true when comparing infected mono-
cytes with uninfected monocytes that had not had contact with viral particles (Fig. 3A
and Fig. S4A).
We then sought to look at expression of these proteins at earlier time points. US28
is a virion-associated protein (19), and incoming US28 is reported to have rapid effects
on host cells (25). We speculated that the downregulation of IFI16, MNDA, and HLA-DR
might occur early during the establishment of latency. For these experiments, we used
TB40/Egfp which marks infected cells with GFP expression via the SV40 promoter and
conﬁrmed the establishment of latency in this system by coculture of monocytes with
ﬁbroblasts either with or without PMA-induced reactivation (Fig. 3B). In our latency
system, we found a stark and speciﬁc loss of IFI16 in infected monocytes from 24 h
postinfection (h.p.i.) (Fig. 3C), a phenotype maintained at 48 and 72 h.p.i. (Fig. 3C) as
measured by immunoﬂuorescence. We quantiﬁed these observations in several ﬁelds of
view for each of these three time points and performed contingency analyses (Fisher’s
exact test), which conﬁrmed speciﬁc loss of IFI16 in latently infected cells (Fig. 3D). Loss
of IFI16 was observed in ex vivo infected monocytes at these time points in a total of
four separate donors with TB40/Egfp virus.
We found a partial downregulation of MNDA by 72 h.p.i. (Fig. 3E and F), with a very
small downregulation at 48 h.p.i. and no effect at 24 h.p.i., suggesting that modulation
of MNDA is delayed compared with a fellow PYHIN family member, IFI16. We also
observed that HLA-DR, but not corresponding MHC class I HLA-A,B,C, was downregu-
lated at 72 h.p.i. speciﬁcally in GFP-positive, latently infected monocytes (Fig. 3G and H).
Therefore, IFI16, MNDA, and HLA-DR are indeed downregulated at early times during
the establishment of latency, with IFI16 showing downregulation within 24 h of infec-
tion.
The downregulation of IFI16 is dependent on viral US28. Having conﬁrmed that
IFI16 is downregulated very early during latent infection of monocytes, we then sought
to establish whether this effect is dependent on US28. We predicted this would be the
case because of the results of our US28 proteomic screen and the established func-
tionality of incoming virion-associated US28 (25). We infected monocytes with either
the US28 WTTB40/EmCherry-US28-3XFLAG HCMV (US38-3XF) or the corresponding
US28 deletion virus TB40/EmCherry-US28Δ (ΔUS28). These viruses establish latent and
lytic infections, respectively, in CD34 progenitor cells, Kasumi-3 cells, and THP-1 cells
(19, 25), and we conﬁrmed that these phenotypes are also maintained in primary
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FIG 3 IFI16, MNDA, and HLA-DR are downregulated in latently infected CD14 monocytes. Primary CD14 monocytes were isolated from peripheral blood or
apheresis cones as described in Materials and Methods. These cells were then infected using bacterial artiﬁcial chromosome (BAC)-derived strains of TB40/E.
(A) CD14monocytes latently infected with TB40/E SV40-mCherry IE2-2A-GFP stained by immunoﬂuorescence for IFI16, MNDA, or HLA-DR as indicated at 4 days
postinfection (d.p.i.) and imaged by wide-ﬁeld ﬂuorescence microscopy. The top left images show uninfected monocytes. The second from the left images show
monocytes that were treated with PMA (PMA) (to permit lytic infection). mCherry (red) serves as a marker for infection, and GFP (green) denotes expression
from the IE2-2A-GFP cassette. The remaining images show monocytes cultured in the absence of PMA. The absence of green ﬂuorescence results from
suppressed expression of the IE2-2A-GFP cassette and scored as IE negative. The magniﬁcation is indicated (40X or 20X). White arrows indicate corresponding
cells in the top and bottom panels. (B) Validation of experimental latency using TB40/Egfp virus. CD14 monocytes were infected and allowed to establish
latency for 4 days (left panel, 10 magniﬁcation). Citrate wash buffer was used to remove externally bound virions. These latently infected cells were cultured
in the presence () or absence () of PMA for 3 days, and at 7 d.p.i., Hff-1 cells were added to the culture to demonstrate production of infectious virions.
Transfer of virus to Hff-1 cells was monitored by ﬂuorescence microscopy up to 13 d.p.i., and infected Hff-1 foci were counted and summed across the
experiment (three wells of CD14 monocytes per condition, graphed). (C) CD14 monocytes infected with TB40/Egfp stained by immunoﬂuorescence for IFI16
at 24, 48, and 72 h.p.i. and imaged as before using 60 magniﬁcation. (D) Quantiﬁcation of IFI16-positive and -negative monocytes in the uninfected and
infected populations from two donors per time point. Raw numbers of cells are indicated in white text. Fisher’s exact test indicates a statistically signiﬁcant
difference between uninfected and infected populations for each time point (P  0.0001). (E) CD14 monocytes infected with TB40/Egfp were stained by
immunoﬂuorescence for MNDA at the indicated times and imaged as before using 60 magniﬁcation. (F) Quantiﬁcation of the signal intensity from infected
monocytes at the indicated time points (n 9, 7, and 10 for the 24-, 48-, and 72-h.p.i. graphs, respectively). MNDA signal intensity in each nucleus was
normalized to the average of uninfected monocytes from each ﬁeld of view. A t test with Welch’s correction was used to determine statistical signiﬁcance.
Statistical signiﬁcance is indicated as follows: ns, not signiﬁcant; *, P  0.05; **, P  0.01. (G) CD14 monocytes infected with TB40/Egfp (with or without UV
inactivation) were analyzed for HLA-ABC and HLA-DR expression at 3 d.p.i. by ﬂow cytometry. The gating strategy for identifying infected cells (GFP) is shown.
FSC, forward scatter. (H) Histogram showing HLA-ABC and HLA-DR staining in HCMV-uninfected GFP-negative (gray) monocytes, and latently infected
GFP-positive (green) monocytes.
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CD14 monocytes by supernatant transfer to permissive ﬁbroblasts (Fig. 4A). We were
also able to detect US28 protein during the establishment of latency in monocytes by
immunostaining for the FLAG epitope tag on the C terminus of US28 (Fig. 4B).
To determine whether US28 speciﬁcally downregulates IFI16 in the context of
infection, we compared the expression of this cellular protein in monocytes infected
with US28-3XF or ΔUS28. Consistent with Fig. 3B, we found that monocytes infected
with the US28-3xF virus showed downregulation of IFI16 at 24 and 48 h.p.i., while
monocytes infected with ΔUS28 displayed robust IFI16 expression at 24 h.p.i. (Fig. 4C
and D) and only partial downregulation at 48 h.p.i. (Fig. 4C and E). These data demon-
FIG 4 IFI16 is rapidly downregulated in a US28-dependent manner during latent infection. CD14 monocytes were infected with either US28 WT
TB40/EmCherry-US28-3XFLAG HCMV or ΔUS28. (A) Validation of the latent and lytic phenotypes associated with US28-3xF and ΔUS28 monocyte infections,
respectively. At 7 d.p.i., supernatant from infected CD14 cells (top panel) were transferred to Hff1 cells (middle bright-ﬁeld and bottom mCherry panels), and
formation of plaques was monitored and imaged at20 magniﬁcation. (B) Detection of US28-3XFLAG during the establishment of latency in CD14monocytes.
At 2 d.p.i., US28-3xF- or ΔUS28-infected CD14 monocytes were ﬁxed and stained by immunoﬂuorescence for US28-3XFLAG using an anti-FLAG antibody and
imaged at 40 magniﬁcation. (C) US28-3XF- and ΔUS28-infected monocytes were stained by immunoﬂuorescence for IFI16 at the indicated times and imaged
using 40 magniﬁcation. White arrows indicate corresponding cells. (D and E) IFI16 signal intensity in each nucleus was normalized to the average of the
uninfected cells in a ﬁeld of view. The results of three ﬁelds of view were then averaged to derive the resulting average signal intensities for each subpopulation
of monocytes at the indicated time points infected with US28-3xF or ΔUS28 HCMV. Statistical signiﬁcance was determined using one-way ANOVA and is
indicated by asterisks as follows: ***, P  0.001; **, P  0.01; *, P  0.05.
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strate that the early downregulation of IFI16 in CD14 monocytes is dependent on
US28.
IFI16 is downregulated by US28 only in undifferentiated myeloid cells. We
previously showed that US28 modulates cellular signaling pathways in undifferentiated,
but not differentiated, THP-1 cells (21). We were therefore curious as to whether the
effects on IFI16 expression were dependent on cellular differentiation status. This is
signiﬁcant because differentiated THP-1 cells and mature dendritic cells are permissive
for HCMV lytic infection. To analyze whether these effects are differentiation depen-
dent, we transduced THP-1 cells with a lentiviral vector that coexpresses US28 and the
ﬂuorescent protein Emerald (US28-UbEm), or coexpresses enhanced GFP (eGFP) and
Emerald (empty UbEm) as a control. For each population, we sorted the Emerald-
positive THP-1 cells by ﬂuorescence-activated cell sorting (FACS) (Fig. S4B) and vali-
dated US28 expression by RT-qPCR (Fig. S4C). We treated half of these cells with PMA
in order to induce cellular differentiation. We found that undifferentiated US28-
expressing THP-1 cells downregulated IFI16, but PMA-differentiated cells did not
downregulate IFI16 (Fig. 5A), suggesting that only latency-associated expression of
US28 attenuates IFI16 expression.
We also analyzed the effect of cellular differentiation on IFI16 expression following
infection in mature dendritic cells derived by treating ex vivo CD14 monocytes with
granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin-4 (IL-4)/lipo-
polysaccharide (LPS). Again, we found that undifferentiated infected CD14monocytes
downregulate IFI16 in a US28-dependent manner at 48 h.p.i., while infected mature
dendritic cells do not downregulate IFI16 with WT or ΔUS28 HCMV (Fig. 5B). Taken
together, our results indicate that US28 rapidly downregulates IFI16 during latent
infection of monocytes, but not during lytic infection of mature dendritic cells.
Low levels of IFI16 are maintained during long-term latency in monocytes and
CD34 progenitor cells. We next assessed whether downregulation of IFI16 and
MNDA occurs during long-term maintenance of latency; long-term downregulation of
HLA-DR is already known to be important for latent carriage of HCMV (41). We infected
monocytes with HCMV that drives mCherry from the GATA2 promoter and maintains
this marker for far longer during latency than SV40 promoter-driven tags (50). At 10 and
14 d.p.i., IFI16 remained absent and MNDA remained partially downregulated in
infected cells (Fig. 5C). We then repeated this analysis in primary CD34 hematopoietic
progenitor cells (HPCs), a site of long-term in vivo latent carriage, as well as the
Kasumi-3 cell line, an experimental model for HCMV latency (51). Consistent with our
observations in monocytes and transcriptome sequencing (RNAseq) experiments in
cord blood-derived CD34 cells (52), IFI16 levels were low or absent in almost all
infected cells imaged at 4 and 10 days postinfection (Fig. 5D and E). Thus, it seems likely
that downregulation of IFI16 is a conserved process in cellular sites of HCMV latency.
IFI16 activates IE gene expression via NF-B in myeloid cells. Having established
that US28 downregulates IFI16 early during the establishment of latency, we wanted to
address why this may be beneﬁcial to the virus for latent infection. One function of IFI16
is the sensing of viral DNA and subsequent induction of type I interferon or interleukin-
1beta (27, 52). While we do not currently rule out a potential role for IFI16-mediated
sensing of HCMV during latency, we were more struck by the previous work identifying
IFI16 as a modulator of host and viral transcription (32–34, 36, 37, 53–58). In particular,
IFI16 is capable of activating the MIEP and driving IE gene expression within the ﬁrst 6 h
of lytic infection of ﬁbroblasts (32, 34), though at later times IFI16 blocks early and late
gene expression (34, 37). Given that a hallmark of HCMV latency is the suppression of
IE gene expression (59), we hypothesized that high levels of IFI16 might drive MIEP
activity and IE gene expression in undifferentiated myeloid lineage cells. To address
this, we transduced and selected THP-1 cells with control empty-vector- or IFI16-
overexpressing lentiviruses to generate control and IFI16-overexpressing cell lines. We
validated IFI16 overexpression by Western blotting (Fig. 6A) and then infected these cell
lines with recombinant HCMV carrying an IE2-YFP (yellow ﬂuorescent protein) cassette
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FIG 5 IFI16 downregulation is maintained during long-term latency of undifferentiated monocytes and CD34 progenitor cells. (A) US28-expressing and
empty-vector-expressing THP-1 cells were either left untreated or treated with PMA for 48 h before cell lysates were harvested. These lysates were then
subjected to Western blotting for IFI16 and actin as a loading control, with molecular weight markers (in kilodaltons) annotated. (B) At 48 h.p.i., either
undifferentiated CD14 monocytes, or monocytes predifferentiated for 7 days with GM-CSF/IL-4/LPS were ﬁxed and stained for IFI16 and imaged as before at
40 magniﬁcation. White arrows indicate corresponding infected cells. (C) CD14 monocytes were infected with HCMV GATA2mCherry or left uninfected. At
the indicated times, cells were ﬁxed and stained for IFI16 or MNDA and imaged as before. (D) Primary CD34 hematopoietic progenitor cells from two donors,
or Kasumi-3 cells, were infected with HCMV GATA2mCherry or left uninfected. At the indicated times, cells were ﬁxed and stained for IFI16 and imaged as before.
(E) Quantiﬁcation of at least three ﬁelds of view from panel D, presented as the proportion of cells with low IFI16 expression in the infected, mCherry-positive
and uninfected, mCherry-negative populations. UI, uninfected. Statistical analysis was performed by Fisher’s exact test on the total number of cells in each
category. Statistical signiﬁcance is indicated by asterisks as follows: ****, P  0.0001; ***, P  0.001; **, P  0.01.
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FIG 6 Overexpression of IFI16 in monocytic cells leads to MIEP activation and IE gene expression via NF-B. (A) THP-1 cells were transduced with empty
vector (EV) or IFI16-overexpressing lentiviruses and after blasticidin selection, IFI16 overexpression was conﬁrmed by Western blotting. Actin is shown
(Continued on next page)
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to allow us to identify cells that express IE2 (60). Undifferentiated THP-1 cells are an
established model for a number of aspects of HCMV latency (61), including the
signiﬁcant repression of IE2 expression (61). When we infected control and IFI16-
overexpressing THP-1 cells with HCMV in ﬁve paired experiments, we found a consis-
tent increase in the number of IE-positive cells in IFI16-overexpressing THP-1 cells
(Fig. 6B and C), suggesting IFI16 overexpression drives IE protein production in cells
that would otherwise repress this viral protein.
Prior work has identiﬁed that IFI16 could activate IE gene expression in a UL83-
dependent manner during lytic infection (32, 37), but since this tegument protein does
not enter the nucleus in the CD34 progenitor cell model of HCMV latency (62), we
hypothesized that IFI16 could activate the MIEP without additional virion components.
To test this hypothesis, we utilized a THP-1 MIEP reporter system; THP-1 cells in which
an integrated 1,151-bp region of the MIEP drives the expression of eGFP (63). In these
undifferentiated THP-1 cells, the MIEP is epigenetically repressed unless stimulated (for
example by differentiation) (63). We treated these MIEP-eGFP THP-1 cells with control
lentiviruses or lentiviruses which drive the overexpression of IFI16, ensuring equivalent
lentivirus infection of reporter cells by a p24 enzyme-linked immunosorbent assay
(ELISA). These cultures were maintained for 2 weeks, after which we validated IFI16
expression by immunoﬂuorescence (Fig. 6D) and then analyzed eGFP expression by
ﬂow cytometry (Fig. 6E). We found that the IFI16-overexpressing cells had increased
eGFP expression compared with controls (Fig. 6D and E), suggesting that IFI16 over-
expressed in isolation and in the absence of additional HCMV components drives MIEP
activity. Furthermore, culturing THP-1 MIEP-eGFP reporter cells with supernatants from
the empty-vector- or IFI16-overexpressing cell lines in Fig. 6A resulted in no signiﬁcant
MIEP activity, suggesting that the effect is mediated intracellularly, and not by a
secreted factor (Fig. 6E).
IFI16 activates NF-B signaling in a number of contexts (53, 64), and our previous
work indicates that US28-mediated attenuation of NF-B signaling is important for the
establishment of latency (21). Therefore, we hypothesized that IFI16 activates the MIEP
via NF-B. We found increased nuclear NF-B localization in IFI16-overexpressing cells
(Fig. 6F), and by using the NF-B pathway inhibitor, BAY11-7082, we were able to
ameliorate the effect of IFI16 overexpression on IE (Fig. 6G and I), suggesting that NF-B
plays an important role in this pathway. Finally, we infected IFI16-overeexpressing cells
with HCMV that lacks NF-B sites within the MIEP (65) to check whether IFI16 exerts its
effects via direct binding of NF-B to the MIEP. In this case, IFI16 overexpression failed
to induce IE gene expression, unlike IFI16 cells infected with the revertant strain (Fig. 6H
and I). Taken together, our data are consistent with the view that IFI16 activates IE gene
expression in early myeloid lineage cells by allowing NF-B to bind at the MIEP.
FIG 6 Legend (Continued)
as a loading control. (B and C) Cells expressing empty vector or overexpressing IFI16 (from panel A) were infected with TB40/E IE2-eYFP (enhanced YFP)
virus, and IE2-YFP-positive nuclei were imaged and counted by ﬂuorescence microscopy. (C) Cumulative results from ﬁve paired experiments, which were
analyzed by paired two-tailed Student’s t test; *, P  0.05. (D) EV and IFI16 lentivirus concentration was determined by p24 ELISA (data not shown) and
15 ng p24 equivalents of each lentivirus was used to transduce MIEP-eGFP THP-1 cells. Cells were maintained for 2 weeks in culture, and IFI16
overexpression was validated by immunoﬂuorescence. (E, left-hand comparison) Cells shown in panel D were assessed for eGFP ﬂuorescence by ﬂow
cytometry. Right-hand comparison, nontransduced MIEP-eGFP-expressing cells were incubated with supernatants from cells described above in the
legend for panel A for 2 days. eGFP expression was quantiﬁed by ﬂow cytometry. A statistical comparison of the median ﬂuorescence intensity was
performed using two-tailed Mann-Whitney test, and statistical signiﬁcance is indicated as follows; ns, not signiﬁcant, *, P  0.05. (F) Empty-vector- or
IFI16-overexpressing cells were ﬁxed and stained for NF-B, with Hoechst as a nuclear stain, at 40 magniﬁcation to assess the levels of nuclear NF-B.
(G) Empty-vector- or IFI16-overexpressing cells were infected with TB40/E IE2-eYFP virus in the presence of the IKK inhibitor BAY11-7082, which inhibits
the NF-B pathway, or DMSO as a control. IE2-eYFP-positive nuclei were imaged and counted by ﬂuorescence microscopy at 48 h postinfection. (H)
Empty-vector- or IFI16-overexpressing cells were infected with a revertant WT-like TB40/E at an MOI of 3 or with TB40/E with NF-B binding sites deleted
from the MIEP (ΔNF-B) at an MOI of 3 or 15. At 48 h.p.i., cells were ﬁxed and stained for IE, and the numbers of IE-positive nuclei were counted. The
graph shows the results of three experiments and statistical analysis by two-way ANOVA using Sidak’s multiple-comparison test. Statistical signiﬁcance
is indicated as follows: **, P  0.01; ns, not signiﬁcant (P  0.05). (I) Empty-vector- or IFI16-overexpressing cells were infected as in panels F and H at
an MOI of 3, but cells were instead analyzed for IE72 expression by RT-qPCR. PCR products were then run on a 2% (IE72) or 1.2% (GAPDH) agarose gel.
UI refers to uninfected cells, DMSO is the solvent control, BAY refers to BAY11-7082, Rev refers to the revertant TB40/E, and ΔNF-B refers to the NF-B
binding site mutant virus. The positive control (ve ctrl) was HCMV-infected PMA-differentiated monocytes. Molecular weight markers (M) are annotated
(in base pairs).
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DISCUSSION
The viral GPCR US28 is expressed during both lytic and latent infection of HCMV.
While US28 is dispensable for lytic replication in vitro (66, 67), it is essential for the
establishment and maintenance of HCMV latency in early myeloid lineage cells (19, 21,
23, 25). This is attributable, in part, to the ability of US28 to suppress the major
immediate early promoter; a US28 function speciﬁc for undifferentiated myeloid cells
(18, 21, 23, 25).
We hypothesized that this ability of US28 to so profoundly regulate viral IE gene
expression in undifferentiated myeloid cells was likely via US28-mediated modulation
of host protein abundance, and therefore, we wanted to determine whether such
US28-driven changes could be important for the establishment or maintenance of
HCMV latency. While previous work has used targeted arrays to assess US28-mediated
effects on myeloid cells (21, 23, 25), here we have used an unbiased proteomic screen
to understand how US28 reprograms host cells in order to support latent infection. Our
screen compared host protein abundance in control THP-1 cells or THP-1 cells which
express either WT-US28 or the US28 signaling mutant US28-R129A. As such, we could
assess the signaling-dependent and signaling-independent effects of US28. We then
chose to focus on signaling-dependent changes because G-protein coupling via the
residue R129A is essential for experimental latency (21, 25). However, we predict that
some of the signaling-independent changes driven by US28 could also be important for
HCMV latency, since these changes included alterations in several cell surface mole-
cules such as costimulatory molecule CD82, adhesion molecule CD44, and in receptor
tyrosine kinase FLT3. The latter two cellular factors are implicated in myeloid cell
differentiation, which is intimately linked with HCMV latency and reactivation (18, 59,
68–70). As such, modulating these cell surface molecules could help to control inter-
actions with immune effectors and cellular differentiation-linked reactivation.
By looking at changes in host protein abundance between US28-WT- and US28-
R129A-expressing THP-1 cells, we found a number of signiﬁcant changes in the host
proteome which likely result speciﬁcally from US28 signaling. Interestingly, we found
US28-WT downregulated a large number of interferon-inducible proteins, including
canonical interferon-stimulated genes (ISGs) like OAS2 and IFITM3, as well as MNDA,
IFI16, and several HLA-DR components. We found that the levels of both total STAT1
and phosphorylated STAT1 were reduced in US28-WT-expressing cells, a mechanism
that may act in synergy with the US28-mediated attenuation of c-fos to downregulate
interferon-inducible genes (25, 47). Modulation of interferon signaling has not previ-
ously been reported for US28, but in the context of the latently infected monocyte, a
general block in downstream interferon signaling may be important for maintaining
the polarization of the monocyte (71, 72) or perhaps to avoid the antiviral activities of
ISGs. We believe these questions merit further interrogation.
We chose to focus on the two PYHIN proteins and the set of HLA-DR components
which are downregulated by US28. We conﬁrmed downregulation of IFI16, MNDA, and
HLA-DR in THP-1 cells which overexpress US28 and recapitulated these effects in
experimental latency in primary CD14monocytes. HLA-DR was previously reported to
be downregulated during experimental latency in granulocyte-macrophage progenitor
cells, which prevents CD4 T cell recognition and activation (41, 73, 74). While this
downregulation of MHC class II involved the expression of the latency-associated gene
UL111A (41), our data argue that viral US28 could also contribute to this phenotype.
Little is known about the function of MNDA, a myeloid-speciﬁc PYHIN protein impli-
cated in neutrophil cell death (75) and monocyte transcriptional networks (76). Ongo-
ing work in our laboratory aims to identify whether US28-mediated downregulation of
MNDA during latent infection could beneﬁt latent carriage and/or reactivation.
Our results clearly characterized a rapid downregulation of IFI16 during the estab-
lishment of latency in monocytes, which occurred within the ﬁrst 24 h of infection and
was also maintained during long-term latency in monocytes and CD34 HPCs. The
early downregulation of IFI16 was clearly US28 dependent, as ΔUS28 virus failed to
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display immediate IFI16 downregulation. However, we did observe a partial downregu-
lation of IFI16 in ΔUS28-infected monocytes at later time points of infection. We think
it likely that this involves an unidentiﬁed lytic-phase viral gene product, which may be
required for overcoming the known IFI16-mediated restriction of HCMV lytic infection
(30, 34, 36, 37) and occurs as a result of ΔUS28 virus initiating a lytic infection in
undifferentiated monocytes.
Our observation that the US28-dependent downregulation of IFI16 occurred rapidly
(within 24 h of infection) may, in part, be attributable to incoming US28 which is
functional (25). IFI16 protein has a short half-life of approximately 150 min in ﬁbroblasts
(77), and therefore, incoming US28 protein may rapidly target IFI16 transcription in
latently infected monocytes, as it does in US28-expressing THP-1 cells, resulting in loss
of IFI16 within 24 h of infection; this is then maintained by subsequent latency-
associated de novo US28 expression.
We found that preventing IFI16 expression has a clear beneﬁt to the establishment
of HCMV latency. This contrasts with previous analyses of latency in other viral systems,
where IFI16 expression is necessary to repress lytic viral transcription (39, 40). In our
study, IFI16 overexpression activated MIEP activity in the absence of additional viral
proteins, and furthermore, IFI16 overexpression increased IE-positive nuclei in latently
infected THP-1 cells. IFI16 activates the MIEP during lytic infection (32, 34), though in
these cases an additional viral gene product, UL83, is thought to be required. Our
results suggest that UL83 is not required for IFI16-mediated activation of the MIEP in
undifferentiated myeloid cells and suggest that IFI16 activates NF-B to achieve this, as
use of either an NF-B pathway inhibitor or deletion of NF-B binding sites from the
MIEP prevented IFI16-mediated IE expression. We believe this provides one mechanism
by which US28 blocks NF-B activity early during latency, a phenomenon we previously
showed to be important for the establishment of latency in myeloid cells (21).
Taken together, our results suggest that one of the early events in the establishment
of latency in CD14 monocytes is the US28-mediated targeting of interferon-
responsive genes, including the downregulation of IFI16, which serves to support the
repression of the MIEP.
MATERIALS AND METHODS
Cells. All cells were maintained at 37°C in a 5% CO2 atmosphere. THP-1 cells (European Collection of
Authenticated Cell Cultures [ECACC] 88081201) were cultured in RPMI 1640 medium (Sigma) supple-
mented with 10% heat-inactivated fetal bovine serum (FBS) (PAN Biotech), 100 U/ml penicillin and
100 g/ml streptomycin (Sigma), and 0.05 mM 2-mercaptoethanol (Gibco). Kasumi-3 cells (ATCC CRL-
2725) were cultured in RPMI 1640 medium (Sigma) supplemented with 20% heat-inactivated FBS (PAN
Biotech) and 100 U/ml penicillin and 100 g/ml streptomycin (Sigma). During infections, THP-1 and
Kasumi-3 cells were cultured in a low-serum (1%) version of this medium for a minimum of 24 h prior to
inoculation and maintained in this low-serum medium throughout the infection. MIEP-eGFP reporter
THP-1 cells (63) were a gift from M. Van Loock (Johnson & Johnson). RPE-1 cells (ATCC CRL-4000) and
human foreskin ﬁbroblasts (Hff1; ATCC SCRC-1041) were maintained in Dulbecco modiﬁed Eagle medium
DMEM (Sigma) supplemented with 10% heat-inactivated FBS and 100 U/ml penicillin and 100 g/ml
streptomycin. 293T cells (ECACC 12022001) were maintained in DMEM (Sigma) supplemented with 10%
heat-inactivated FBS but without penicillin or streptomycin. Phorbol 12-myristate 13-acetate (PMA)
(Sigma) was used to induce myeloid cell differentiation at a concentration of 20 ng/ml.
Primary CD14 monocytes were isolated from apheresis cones (National Health Services [NHS] Blood
& Transplant Service) or from peripheral blood samples taken from healthy volunteers as previously
described (78). Brieﬂy, CD14 monocytes were isolated from total peripheral blood mononuclear cells
(PBMC) by magnetically activated cell sorting (MACS) using CD14 microbeads (Miltenyi Biotech). The
monocytes were plated on tissue culture dishes (Corning) or slides (Ibidi), or kept in suspension in X-Vivo
15 medium (Lonza) supplemented with 2 mM L-glutamine. Mature dendritic cells were generated by
treating CD14 monocytes with granulocyte-macrophage colony-stimulating factor (GM-CSF) (Miltenyi)
(1,000 U/ml) and interleukin-4 (IL-4) (Miltenyi) (1,000 U/ml) for 5 days before the addition of lipopolysac-
charide (LPS) (Invivogen) (50 ng/ml) for 2 further days.
Primary human CD34 hematopoietic progenitor cells, isolated from adult bone marrow, were
purchased from STEMCELL Technologies and cultured in X-Vivo 15 medium (Lonza).
Ethics statement. All human samples were obtained under ethical approval and after approval of
protocols from the Cambridgeshire 2 Research Ethics Committee (REC reference 97/092), and all
protocols were conducted in accordance with the Declaration of Helsinki. Informed written consent was
obtained from all of the volunteers included in this study prior to providing blood samples, and all
experiments were conducted in accordance with the approved guidelines.
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Generation of lentiviruses and retroviruses. The lentiviral vectors encoding US28 from the VHL/E
strain of human cytomegalovirus (HCMV) have been described previously (21); US28 is expressed in these
vectors via the spleen focus-forming virus (SFFV) promoter. The lentiviral vectors pHRSIN UbEm and
pHRsin SV40blast were a kind gift from D. van den Boomen, University of Cambridge, and were based
upon a previously published lentiviral system (79, 80). Brieﬂy, expression of the gene of interest is also
driven by the SFFV promoter, and the selectable markers Emerald and blasticidin resistance are driven
by the ubiquitin promoter (UbEm) and the SV40 promoter (SV40blast), respectively. The sequence
encoding US28 from the VHL/E strain of HCMV was cloned into pHRSIN UbEm using the EcoRI and SpeI
sites using the following primers: US28 FW (FW stands for forward), 5= GCAcgaattccatatgacgccgacgacgac,
and RV (RV stands for reverse), 5=-CTGCACTAGTTTACGGTATAATTTGTGAGAC. The sequence encoding
IFI16 was cloned into pHRsin SV40blast using the BamHI and NotI sites using the following primers: IFI16
FW, 5=-GATTGCGGCCGCATGGGAAAAAAATACAAGAACATTGTTC and RV, 5=-GATCGGATCCTTAGAAGAAA
AAGTCTGGTGAAGTTTC.
The sequence encoding US28-3XFLAG was cloned from TB40/EmCherry-US28-3XFLAG into the
retroviral plasmid pBABE eGFP (a gift from Debu Chakravarti [Addgene plasmid no. 36999]) as described
previously (25). The Q5 site-directed mutagenesis kit (New England Biotech) was used to generate the
US28-R129A mutant of this vector, which was veriﬁed by Sanger sequencing. Expression of US28 in these
vectors is driven by the long terminal repeat and partial gag.
Generation of vesicular stomatitis virus G protein (VSV-G) pseudotyped lentiviral particles was
conducted generally in line with the Broad Institute Protocols. Five hundred thousand 293T cells were
transfected with 1,250 ng of lentiviral expression vector, 625 ng of lentiviral packaging vector psPAX, and
625 ng of envelope vector pMD.2G (both gifts from S. Karniely, Weizmann Institute, Israel) using
transfection reagent FuGene6 (Promega) according to the manufacturer’s instructions. For generation of
VSV-G pseudotyped retrovirus particles, 1,250 ng of the murine leukemia virus retroviral packaging
vector KB4 (81) (a gift from H. Groom, University of Cambridge) was transfected along with 625 ng
pMD.2G and 1250 ng retroviral expression vector.
Lentiviral and retroviral transduction. Supernatants from transfected 293T cells were harvested at
36 and 60 h posttransfection, ﬁltered through a 0.45-m syringe ﬁlter, and used to transduce THP-1 cells
in the presence of 2 g/ml Polybrene. When necessary, lentiviral titers were determined by in-house p24
enzyme-linked immunosorbent assay (ELISA). For transduction with puromycin resistance vectors, pu-
romycin (2 g/ml, Sigma) was added to media and refreshed every 2 to 5 days until all control
nontransduced THP-1 cells were dead. Similarly, where blasticidin resistance vectors were used, blasti-
cidin (1 g/ml; Invivogen) was added to media. Emerald-positive cells were sorted using a BD FACSAriaIII
instrument.
Human cytomegaloviruses. Infection of monocytes and THP-1 cells was conducted at a multiplicity
of infection (MOI) of 3 as determined by titration on RPE-1 cells. TB40/E BAC4 strains were propagated
in RPE-1 cells by seeding 50% conﬂuent T175 ﬂasks with virus at an MOI of 0.1. Spread of virus was
monitored for 2 to 6 weeks following inoculation by ﬂuorescence microscopy, and infected monolayers
were subcultured twice during this period. When cells were 95 to 100% infected, supernatants were
harvested on three occasions spaced over 7 days and stored at –80°C. In the ﬁnal harvest, the monolayer
was scraped and also stored at –80°C. After thawing the virus-containing media, cell debris was pelleted
by centrifugation at 1,500 g for 20 min at room temperature. Then, the clariﬁed supernatant was
concentrated by high-speed centrifugation at 14,500 g for 2 h at 18°C. Virus-containing pellets were
then resuspended in X-Vivo 15 medium in aliquots at –80°C.
TB40/EmCherry-US28-3XFLAG and TB40/EmCherry-US28Δ have been described previously (19). TB40/
Egfp (82) and TB40/E BAC4 SV40 mCherry IE2-2A-GFP (83) were kind gifts from E. A. Murphy, SUNY
Upstate Medical University. TB40/E BAC4 IE2-eYFP has been described previously (60, 84). TB40/E BAC4
GATA2mCherry has been described previously (50). TB40/E with deleted NF-B sites in the MIEP at
positions 94, 157, 262, and 413 and the revertant virus were a kind gift from Jeffery Meier and
Ming Li (University of Iowa, United States) and have been described previously (65).
UV inactivation of virus was performed by placing a 100-l aliquot of virus in one well of a 24-well
plate and placing this within 10 cm of a UV germicidal (254-nm) lamp for 15 min, which routinely results
in no detectable IE gene expression upon infection of Hff1 cells.
Immunoﬂuorescence staining and image analysis. Cells were ﬁxed with 2% paraformaldehyde for
15 min and permeabilized with 0.1% Triton X-100 for 10 min at room temperature. Blocking and antibody
incubations were performed in phosphate-buffered saline (PBS) with 1% bovine serum albumin and 5%
normal goat serum. The following antibodies were used: anti-IFI16 (Santa Cruz sc-8023, 1:100), anti-FLAG
(Sigma F1804, 1:1000), anti-MNDA (Cell Signaling Technology 3329, 1:100), anti-IE (Argene 11-003,
1:1,000 or directly conjugated to ﬂuorescein isothiocyanate [FITC], 1:100), anti-GFP (directly conjugated
to FITC, Abcam ab6662, 1:200), anti-mCherry (Abcam ab167453, 1:500), anti-HLA DR (conjugated to
Brilliant Violet 421, Biolegend clone L423 or Abcam ab92511, 1:100). Cells were imaged with a wide-ﬁeld
Nikon TE200 microscope, and images were processed using ImageJ. For contingency analyses of IFI16
expression during experimental latency, cells were assigned as “IFI16 positive/negative” and “infected/
uninfected” and then counted. These results were then analyzed using Fisher’s exact statistical test for
signiﬁcance. For analysis of signal intensity, nuclear stained images were used to create a mask from
which intensity values of the corresponding IFI16/MNDA-stained image were derived using the Analyze
Particles feature of ImageJ. Cells were assigned as infected or uninfected based on signal from the
GFP/mCherry stain. The average signal intensity of uninfected cells was used to normalize the signal
intensity in order to compare different ﬁelds of view.
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Inhibitors. The c-fos inhibitor T5524 was purchased from Cayman Chemical, solubilized in dimethyl
sulfoxide (DMSO) and used at 10 M. The Janus kinase inhibitor Ruxolitinib was purchased from Cell
Guidance Systems, solubilized in DMSO and used at 5 M. The IB kinase alpha (IKK) inhibitor/NF-B
pathway inhibitor BAY11-7082 was purchased from Santa Cruz, solubilized in DMSO, and used at a
concentration of 5 M.
Western blotting. Except for US28 blots, cells were lysed directly in Laemmli buffer and separated
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Following transfer to nitro-
cellulose, the membrane was blocked in 5% milk in Tris-buffered saline (TBS) with 0.1% Tween 20. The
following antibodies were used: anti-IFI16 (Santa Cruz sc-8023, 1:500), anti-MNDA (Cell Signaling Tech-
nology 3329, 1:250), anti-STAT1 (Cell Signaling Technology 14994, 1:1,000), anti-phosphoSTAT1 Tyr701
(Cell Signaling Technology 9167, 1:1,000), and anti-beta actin (Abcam ab6276, 1:5,000). For US28 blots,
cells were pelleted, washed once in ice-cold PBS, and then lysed in native lysis buffer (25 mM Tris HCl [pH
7.4], 150 mM NaCl, 1 mM EDTA, 1% NP-40, 5% glycerol, plus protease inhibitors) for 30 min, vortexing
every 10 min. After the addition of nonreducing Laemmli buffer, samples were heated at 42°C for 10 min
and then separated by SDS-PAGE. Polyvinylidene diﬂuoride membranes were used for transfer, and
blocked membranes were incubated with the rabbit anti-US28 antibody (85) (a gift from M. Smit, Vrije
University) at 1:1,000 dilution. To quantify Western blots, the Analyze Gels feature of Image J was used
to plot the band intensities. The signals for genes of interest were then normalized to those of
US28-R129A cells and then normalized to either the relative amounts of actin or STAT1 as described in
the ﬁgure legends.
Flow cytometry. Transduced THP-1 cells and MIEP reporter THP-1 cells were analyzed on a BD Accuri
instrument. Live cells were gated using forward and side scatter. Paraformaldehyde-ﬁxed cells were
stained using anti-HLA-DR allophycocyanin (APC) conjugate (Biolegend, clone L243, 1:50). Latently
infected CD14 monocytes were ﬁxed with 1% paraformaldehyde and stained using anti-HLA-DR Paciﬁc
blue conjugate (Biolegend, clone L243, 1:50) and anti-HLA-A,B,C, phycoerythrin (PE)-Cy7 conjugate
(Biolegend, clone W6/32, 1:50), before analysis on the Nxt Attune instrument (Thermo Fisher Scientiﬁc).
RNA extraction, reverse transcription, and quantitative PCR. RNA was extracted and puriﬁed
using Direct-Zol RNA MiniPrep kit (Zymo Research) according to the manufacturer’s instructions. A total
of 5 ng of puriﬁed RNA was used in reverse transcription-quantitative PCR (RT-qPCR), performed using
QuantiTect SYBR Green RT-PCR kit reagents (Qiagen) on a StepOne Real-Time PCR instrument (Applied
Biosystems). TATA box binding protein (TBP) was used as a reference gene, and fold changes were
analyzed by the 2ΔΔCt method. Reverse transcription was performed using the Qiagen QuantiTect
Reverse Transcription kit, and then cDNA was used in qPCR analysis using New England Biotech LUNA
SYBR green qPCR reagents using TBP or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a
reference gene. The following primers were used: US28 FW, AATCGTTGCGGTGTCTCAGT; US28 RV,
TGGTACGGCAGCCAAAAGAT; MNDA FW, GGAAGAAGCATCCATTAAGG; MNDA RV, GTTTGTCTAGACAGGC
AAC; IFI16 FW, CTGCACCCTCCACAAG; IFI16 RV, CCATGGCTGTGGACATG; TBP FW, CGGCTGTTTAACTTCG
CTTC; TBP RV, CACACGCCAAGAAACAGTGA; HLA-DRA FW, TGTAAGGCACATGGAGGTGA; HLA-DRA RV,
ATAGGGCTGGAAAATGCTGA; IE72 FW, GTCCTGACAGAACTCGTCAAA; IE72 RV, TAAAGGCGCCAGTGAATT
TTTCTTC; GAPDH FW, TGCACCACCAACTGCTTAGC; and GAPDH RV, GGCATGGACTGTGGTCATGAG.
Sequence alignment. US28 sequences were exported from GenBank (TB40/E BAC4 EF999921.1,
AD169 FJ527563.1, Merlin NC_006273.2, and VHL/E MK425187.1) or from sequenced plasmids and
aligned using Clustal Omega (86) (https://www.ebi.ac.uk/Tools/msa/clustalo/) and the output format
MView (87).
Cell lysis, digestion, and cleanup for proteomic analysis. Cells were harvested by centrifugation and
washed three times in cold phosphate-buffered saline before ﬁnally pelleting into a low-adhesion microcen-
trifuge tube. Cell pellets were lysed in 2% 50mM triethylammonium bicarbonate (TEAB) (pH 8.5). Samples
were quantiﬁed by bicinchoninic acid (BCA) assay, and 50g of each sample was taken and adjusted to the
same volume with lysis buffer. Reduction and alkylation were achieved by the addition of 10mM Tris
(2-carboxyethyl)phosphine (TCEP) and 20mM iodoacetamide for 20 min at room temperature in the dark
followed by quenching with 10 mM dithiothreitol (DTT). Samples were further puriﬁed and digested using a
modiﬁed ﬁltered aided sample prep (FASP) protocol. Brieﬂy, samples were brought to 500-l volumewith 8M
ureaTEAB and loaded onto a 30-kDa molecular-weight-cutoff (MWCO) ultraﬁltration device. The samples
were then washed three times with 8M ureaTEAB and then washed three times with 0.5% sodium
deoxycholate (SDC)50mM TEAB. Samples were ﬁnally resuspended in 50l of SDCTEAB containing
1g trypsin and incubated overnight at 37°C. After digestion, samples were recovered from the ﬁlter device
by centrifugation, acidiﬁed to precipitate SDC and cleaned up by two-phase partitioning into 2 volumes of
ethyl acetate (repeated twice) before drying in a vacuum centrifuge.
TMT labeling. Samples were resuspended in 20l of 100mM TEAB, and to each tube 0.2g of a unique
tandem mass tag (TMT) label for each sample was added in 8.5 l acetonitrile (ACN) and incubated for 1 h
at room temperature. TMT reactions were quenched by the addition of 3 l of 200mM ammonium formate,
pooled, and dried in a vacuum centrifuge. The sample was then resuspended in 800 l of 0.1% triﬂuoroacetic
acid (TFA) and acidiﬁed to pH 2 with formic acid (FA) before performing a C18 solid-phase extraction
(C18-SPE) using a Sep-Pak cartridge (Waters) attached to a vacuum manifold. C18 eluate was dried in a
vacuum centrifuge and resuspended in 40 l od 200mM ammonium formate, pH 10.
High-pH reverse-phase fractionation. The samples were injected onto an Ultimate 3000 RSLC
UHPLC system (Thermo Fisher Scientiﬁc) equipped with a 2.1 mm inner diameter (i.d.)  25 cm, 1.7-m
particle Kinetix Evo C18 column (Phenomenex). The mobile phase consisted of solvent A (3% ACN),
solvent B (ACN), and solvent C (200 mM ammonium formate [pH 10]). Isocratic conditions were 90%
solvent A10% solvent C, and solvent C was maintained at 10% throughout the gradient elution.
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Separations were conducted at 45°C. After loading at 200 l/min for 5 min and ramping the ﬂow rate to
400 l/min over 5 min, the gradient elution proceeded as follows: 0 to 19% solvent B over 10 min (curve
3), 19 to 34% solvent B over 14.25 min (curve 5), 34 to 50% solvent B over 8.75 min (curve 5), followed
by a 10-min wash with 90% solvent B. UV absorbance was monitored at 280 nm, and 15-second fractions
were collected into 96-well microplates using the integrated fraction collector. Peptide containing
fractions were then orthogonally recombined into 24 fractions, dried in a vacuum centrifuge, and
resuspended in 10 l of 5% DMSO0.5% TFA for analysis.
Liquid chromatography (LC)-mass spectrometry (MS) analysis. All samples were injected onto an
Ultimate 3000 RSLC nano UHPLC equipped with a 300-m i.d.  5-mm Acclaim PepMap -Precolumn
(Thermo Fisher Scientiﬁc) and a 75-m i.d.  50-cm 2.1-m particle Acclaim PepMap RSLC analytical
column. The loading solvent was 0.1% TFA, analytical solvent A was 0.1% FA, and analytical solvent B was
ACN plus 0.1% FA. All separations are conducted at 55°C. Samples were loaded at 10 l/min for 5 min in
loading solvent before beginning the analytical gradient. For high-pH reverse-phase (RP) fractions, a
gradient of 3 to 5.6% analytical solvent B over 4 min, 5.6 to 32% analytical solvent B over 162 min,
followed by a 5-min wash with 80% analytical solvent B, a 5-min wash with 90% analytical solvent B, and
equilibration at 3% analytical solvent B for 5 min. During the gradient, the Orbitrap Fusion mass
spectrometer (Thermo Fisher Scientiﬁc) was set to acquire spectra according to the settings given in
Table S1 in the supplemental material (in “MS Settings”).
Data processing. All raw ﬁles were searched by Mascot within Proteome Discoverer 2.1 (Thermo
Fisher Scientiﬁc) against the Swissprot human database and a database of common contaminants.
The search parameters were as follows: enzyme, trypsin; MS1 tolerance (tol), 10 ppm; MS2 tol, 0.6 Da;
ﬁxed modiﬁcations, carbamidomethyl cysteine, TMT peptide N termini and lysine; variable modiﬁcation,
oxidized methionine; MS3 reporter ion tol, 20 ppm, most conﬁdent centroid. Mascot Percolator was used
to calculate peptide spectrum match false-discovery rate (PSM FDR).
Search results were further processed and ﬁltered as follows. Peptides below a percolator FDR of
0.01% and proteins below the 0.01% protein FDR (calculated from a built-in decoy database search) were
rejected. Protein groups were then generated using the strict parsimony principle. Peptides both unique
and razor with a coisolation threshold of 50 and an average signal-to-noise (s/n) threshold of 10 were
used for quantiﬁcation, and a normalization of these values to the total peptide amount in each channel
was applied. Instances where a protein was identiﬁed but not quantiﬁed in all channels were rejected
from further analysis. “Scaled” abundances of proteins provided by Proteome Discoverer were used to
derive ratios of abundance. q values of signiﬁcance between groups were calculated by Benjamini-
Hochberg correction of P values generated using the moderated T-test LIMMA within the R environment.
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